A previous study utilizing genome-scale CRISPR gene editing has revealed decreased MZ-1 activity in MM cells treated with sgRNAs against genes including CUL2, VHL, TCEB2, TCEB1, RBX1, UBE2R2, and LZTR1 [59]. The gene discussed is RBX1; the disease is Miyoshi myopathy.